Few studies demonstrated that geriatric impairments may increase the risk of immune-related adverse events in older patients treated with ICIs; however, an association did not reach statistical significance [ 12 , 13 ].
← all excerpts
Toxicity in Older Patients with Cancer Receiving Immunotherapy: An Observational Study.
1
—
—